Home > Boards > US Listed > Biotechs > Teva Pharmaceutical (TEVA)

Teva owes NIS 2.1b taxes on trapped profits

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
midastouch017 Member Profile
 
Followed By 114
Posts 24,753
Boards Moderated 6
Alias Born 02/07/04
160x600 placeholder
European Commission Fines Teva, Cephalon EUR60.5 Million for Antitrust Violation Dow Jones News - 11/26/2020 7:52:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 11/5/2020 7:01:16 AM
Teva Reports Third Quarter 2020 Financial Results Business Wire - 11/5/2020 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 11/3/2020 7:43:10 AM
Teva, Amazon Web Services and Onica Announce Collaboration to Support Teva’s Digihaler® Portfolio Business Wire - 10/21/2020 8:00:00 AM
Shield Therapeutics: Peer Teva Pharmaceutical Industries Withdraws Oppositions to Patents Dow Jones News - 10/19/2020 3:14:00 AM
iBio Announces Appointment of Dr. Alexandra Kropotova to Board of Directors GlobeNewswire Inc. - 10/15/2020 7:30:10 AM
Teva Announces New Analysis of Consistency in Migraine Days Over the Course of a Dosing Regimen for AJOVY® (fremanezumab-vfr... Business Wire - 10/7/2020 8:00:00 AM
Teva Canada annonce la mise en marché d'Aermony RespiClickMC, un nouveau dispositif novateur dans le traitement de l'asthme ... PR Newswire (Canada) - 10/5/2020 8:00:00 AM
Teva Canada annonce la mise en marché d’Aermony RespiClickMC, un nouveau dispositif novateur dans le traitement de l’ast... Business Wire - 10/5/2020 8:00:00 AM
Teva Canada announces availability of Aermony RespiClick™, an innovative new device for the treatment of bronchial asthma PR Newswire (Canada) - 10/5/2020 8:00:00 AM
Teva Launches First Generic Versions of HIV-1 Treatments TRUVADA® (emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg... Business Wire - 10/2/2020 8:00:00 AM
Teva to Host Conference Call to Discuss Third Quarter 2020 Financial Results at 8 a.m. ET on November 5, 2020 Business Wire - 10/1/2020 11:06:00 AM
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate & salmeterol) Inhalation Powder ... Business Wire - 9/21/2020 8:00:00 AM
First Long-Term Data on the use of AJOVY® (fremanezumab-vfrm) Injection in Patients with Migraine Published in Neurology Business Wire - 9/15/2020 8:00:00 AM
Teva to Present New Data at The MDS Virtual Congress 2020 & Psych Congress 2020 Virtual Experience Evaluating Long-Term Treat... Business Wire - 9/14/2020 8:00:00 AM
Teva to Present New Data on AUSTEDO® (deutetrabenazine) Tablets at the MDS Virtual Congress 2020 & Psych Congress 2020 Virtu... Business Wire - 9/8/2020 8:00:00 AM
Initial Statement of Beneficial Ownership (3) Edgar (US Regulatory) - 9/3/2020 4:10:25 PM
Indictment Came After Failed DOJ, Teva Talks -- WSJ Dow Jones News - 8/28/2020 3:02:00 AM
Teva's Indictment Came After Talks Faltered with Justice Department Dow Jones News - 8/27/2020 5:21:00 PM
Teva Indicted in Price Case -- WSJ Dow Jones News - 8/26/2020 3:02:00 AM
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges -- 4th Update Dow Jones News - 8/25/2020 10:14:00 PM
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges -- 3rd Update Dow Jones News - 8/25/2020 8:43:00 PM
Statement in Response to News of the Indictment of Teva USA Business Wire - 8/25/2020 8:39:00 PM
Teva Pharmaceutical's U.S. Unit Indicted on Price-Fixing Charges -- 2nd Update Dow Jones News - 8/25/2020 7:57:00 PM
midastouch017   Sunday, 11/10/13 11:49:19 AM
Re: None
Post # of 3531 
Teva owes NIS 2.1b taxes on trapped profits

Assuming that Check Point pays a tax rate of 5-6%, its tax liability will be $82-102 million (NIS 300-360 million).
10 November 13 17:31, Tali Tsipori


Check Point Software Technologies Ltd. (Nasdaq: CHKP), Israel Chemicals Ltd. (TASE: ICL), and Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) are members of an exclusive club of corporations that obtained huge tax breaks and were exempt from the companies tax under the Law for the Encouragement of Capital Investment. Now with the pending deadline of the directive granting a discount on taxes on dividends paid from trapped profits, the companies are "compelled" to open their wallets and pay some taxes. Nonetheless, the tax that some companies have agreed, or will agree, to pay is a fraction of the full amount they would have paid were it not for the directive.
We will begin with the biggest of the three companies, Teva. The Israeli generic giant, which is going through a serious management crisis and has a market cap of $32.5 billion, stated in its financial report for the third quarter that it has $15.14 billion (NIS 53.5 billion) in trapped profits, and if it were to pay tax on the distribution of a dividend from them, the tax would total $2.13 billion (NIS 7.5 billion).
This is only theoretical. The trapped profits law is the result of the Law for the Encouragement of Capital Investment, which was enacted in 1959, to encourage investment in Israel. The law states that any company defined as an "approved enterprise" is eligible for tax breaks; in effect paying a negligible tax rate. It also states that a company subject to the law that wants to distribute dividend from the untaxed profits will pay a dividend tax of 15% on top of the companies tax rate of 25%, for a total tax rate of 40%.
This condition resulted in corporations, which accumulated huge profits over the decades, not distributing dividends because of the tax liability that would have applied. To avoid paying the tax, they essentially trapped the untaxed profits. The result was the trapped profits law, which basically allows the corporations to pay a much lower tax rate than the 15% rate on dividends distributed from the untaxed profits, and releases them from paying the 25% companies tax.
In effect, the law grants the companies an additional tax break. The law sets out different tax plans, and there is no uniform tax rate for all companies, so it is possible that some companies will pay far less than the 15%.
As for Teva, it stated in its latest financial report that if it utilizes the trapped profits law, it would pay a maximum one-time tax assessment of $700 million (NIS 2.5 billion), or a tax rate of just 4.6%. In May, the company said that it would pay NIS 336 million in taxes on NIS 5.5 billion in trapped profits (a tenth of its total trapped profits), a tax rate of just 6.1%.
On the basis of Teva's statement that its tax assessment will be $700 million, and excluding what it paid in May, the question is: Will Teva pay NIS 2.1 billion in taxes to the Israel Tax Authority?
As for Check Point, which has a market cap of $11.6 billion, it stated in its financial report for the third quarter that it has $1.7 billion in trapped profits. Check Point, in contrast to Teva, did not mention the amount of its tax assessment, so at this point it is only possible to use Teva's tax assessment as a baseline for an estimate. Assuming that Check Point pays a tax rate of 5-6%, its tax liability will be $82-102 million (NIS 300-360 million).

Published by Globes [online], Israel business news - www.globes-online.com - on November 10, 2013

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences